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The characteristic histological feature of pancreatic mucinous cystic neoplasm (MCN) is ovarian-like stroma (OS)
underlying the epithelium and existence of estrogen receptors and progesterone receptors in the nucleus of OS.
We experienced a case of pancreatic MCN which was activated during pregnancy and confirmed the existence of
estrogen receptors and progesterone receptors. In cases with potential factors for malignancy, surgical resection of
MCN may be needed during pregnancy. On the other hand, in cases without these, as female sex hormones may
have an influence on the behavior of pancreatic MCN during pregnancy, the timing of surgery should be decided
on a case-by-case basis, taking into consideration the status of the malignancy, the stage of the pregnancy, and the
condition of the mother and fetus.
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A mucinous cystic neoplasm (MCN) is relatively rare,
accounting for about 8% of resected cystic lesions of the
pancreas [1]. And the characteristic histological feature
is ovarian-like stroma (OS) underlying the epithelium
[2]. As with an ovarian MCN, estrogen receptors (ER)
and progesterone receptors (PgR) are expressed in OS
of pancreatic MCN [3], indicating that female sex
hormones may have an influence on the behavior of
pancreatic MCN, especially during pregnancy. We ex-
perienced a patient with pancreatic MCN which was
activated during the pregnancy. Herein, we introduce
the case, together with a literature review of MCN dur-
ing pregnancy.
Case presentation
A 33-year-old woman who was 4 months pregnant com-
plained of left back pain. Abdominal ultrasound revealed
a 60-mm cystic mass in the body and tail of the pan-
creas without a mural nodule or thickening of the wall
(Figure 1a). The serum cancer antigen (CA) 19-9 level* Correspondence: hdobaba@kumamoto-u.ac.jp
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in any medium, provided the original work is pwas elevated, at 92 U/mL (normal level is <37 U/mL), and
then rapidly rose to 2,157 U/mL just before delivery.
The patient's antenatal course was uneventful, and
the delivery was normal. After delivery, magnetic reson-
ance imaging revealed that the cystic tumor was 76 mm
in diameter, with a thickening septum seen on T2-
weighted imaging (Figure 1b). In addition, fluorodeoxyglu-
cose positron emission tomography-computed tomography
(FDG-PET/CT) showed an abnormally high uptake in
part of the cystic tumor (Figure 1c). As FDG-PET/CT
imaging indicated that malignancy could not be exclu-
ded, the patient underwent distal pancreatectomy on
the 14th day after delivery (Figure 2a,b). Microscopically,
the cyst wall was lined with benign mucinous colum-
nar epithelium underlying OS (Figure 3a). In addition,
immunohistochemical analysis showed that both ER
and PgR were partially positive in the nucleus of OS
(Figure 3b,c).
All pancreatic MCNs should be resected because they
are considered as having malignant potential [4]. As in-
crease in tumor size, mural nodules, and eggshell calci-
fication predict malignant MCN [5], the ideal strategy
is to remove the MCN surgically before these predic-
tors develop. However, it is difficult to determine the
best timing for surgery when pancreatic MCN is detectedan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Imaging studies. (a) A 60-mm cystic mass was detected in the body and tail of the pancreas without a mural nodule or thickening of
the wall by abdominal ultrasound (during the fourth month of gestation). (b) Magnetic resonance imaging (MRI) showed a 76 × 69-mm cystic
tumor (arrow), in which the contents were hyperintense in T2-weighted imaging. There were septa in the tumor, and one part of it was thickened
and enhanced. (c) Fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) showed high uptake (arrow) in part
of the cystic tumor (SUVmax 3.03).
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an accurate diagnosis of malignancy is difficult, especially
for borderline cases. Second, it is necessary to consider
the effects of surgery on the mother and the fetus.
We analyzed the clinical characteristics of MCNs de-
tected during pregnancy according to data extracted
from our case and previous reports [6-24], as well as
our own experience (Table 1). In the reports reviewed,
12 patients underwent surgery during pregnancy, andFigure 2 Intraoperative findings and macroscopic observations. (a) A
(arrowheads indicating the tumor). Distal pancreatectomy was performed.
solid components.neither miscarriage nor operation-related death oc-
curred in any of the patients. Eight patients underwent
operation after delivery. Regarding histopathological diag-
nosis, 14 patients were diagnosed with benign MCN,
and 6 patients, 3 patients underwent operation during
pregnancy and 3 patients after delivery, were diagnosed
with adenocarcinoma. Among the six patients with ade-
nocarcinoma, at least four patients were alive 1 year after
resection.smooth cystic tumor occupied the body and tail of pancreas
(b) The cut surface of the tumor showing a large cyst without
Figure 3 Analysis of pancreatic mucinous cystic adenoma by immunohistochemistry. (a) The cyst wall was lined with benign mucinous
columnar epithelium underlying OS (Hematoxylin and eosin, ×100). (b) Immunohistochemical studies showed partial positive staining for
estrogen receptors in the nucleus of ovarian-type stroma (×100). (c) Immunohistochemical studies showed partial positive staining for progesterone
receptors in the nucleus of ovarian-type stroma (×100).
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ence of ER and PgR. In addition, we confirmed rapid
growth of MCN during pregnancy in nine patients,
and at least seven patients of them showed positive
staining for ER or PgR. Interestingly, Tanaka et al.
reported a case of MCN developing during continu-
ous hormone replacement therapy after hysterectomy.
These findings suggested that the existence of ER
and PgR might contribute to the activation of MCN
during pregnancy.
Although the cutoff value of size and the mural nodule
diameter for predicting malignancy has not been deter-
mined, it was generally reported that factors for predict-
ing malignant MCN were large size and the existence of
mural nodes [25]. In our case, we detected not only the
two signs of malignant MCN but also an elevated
CA19-9 level from 92 to 2,157 U/mL. A CA19-9 con-
centration >37 U/mL had a positive predictive value of
95.7% for potentially malignant lesions, but only showed a
sensitivity of 35.8% [26]. In Table 1, five of the six patients
showed the elevation of serum CA19-9 level, and the
serum CA19-9 level of the patient with adenocarcinoma
was remarkably higher. However, we could not find any
relationships between the expression of hormone recep-
tors and CA19-9 level, so further studies are necessary
to validate the relationship between tumor markers and
clinicopathological features including malignancy and
hormone receptors.In cases with potential factors for malignancy like large
size and thickening septum, surgical resection of MCN
may be needed. On the other hand, no findings of malig-
nancy may enable the extension of surgical resection
until delivery. In evaluating the possibility of malignant
status of a MCN, consideration must be given to the
stage of pregnancy and the condition of the mother and
the fetus, and the timing of surgery should be decided
on a case-by-case basis. Moreover, in view of the existence
of ER and PgR, careful observation is necessary concern-
ing the growth and progression of MCN.
Conclusions
In cases with potential factors for malignancy, surgical
resection of MCN may be needed during pregnancy. On
the other hand, in cases without these, as female sex
hormones may have an influence on the behavior of
pancreatic MCN during pregnancy, the timing of sur-
gery should be decided on a case-by-case basis, taking
into consideration the status of the malignancy, the
stage of the pregnancy, and the condition of the mother
and fetus.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Table 1 Literatures review of clinical characteristics of mucinous cystic neoplasm during pregnancy





CA19-9 (U/mL) Timing of operation Histological diagnosis ER/PgR Prognosis (years)
Smithers [6] 33 10 NA NA During pregnancy Adenocarcinoma NA NA
Baiocchi [7] 29 NA NA NA After delivery Adenocarcinoma NA Alive (2)
Olsen [8] 25 5 0 NA During pregnancy Benign NA
Ganepola [9] 37 12 65 NA During pregnancy Benign +/+
Kato [10] 33 22 + NA During pregnancy Benign +/+
Matsunaga [11] 28 20 + NA During pregnancy Adenocarcinoma −/+ NA
Fernandez [12] 26 15 NA NA During pregnancy Benign NA
Herring [13] 34 20 80 NA During pregnancy Adenocarcinoma +/+ Alive (NA)
Ozden [14] 32 15 NA NA After delivery (emergency cesarean) Adenocarcinoma −/− Alive (1)
Ishikawa [15] 33 18 60 NA After delivery Benign −/−
Ikuta [16] 30 18 NA Normal After delivery (abortion) Benign +/+
Hakamada [17] 38 14 40 NA During pregnancy Benign NA/+
Wiseman [18] 32 15 NA NA During pregnancy Benign +/+
Brown [19] 38 10 NA NA During pregnancy Benign NA
Shirakawa [20] 34 19 0 Elevated After delivery Benign +/+
Asciutti [21] 31 8 65 214 After delivery Benign NA
Nagamura [22] 32 11 NA 4,750 After delivery (emergency cesarean) Adenocarcinoma −/+ Alive (3)
Boyd CA [23] 21 17.2 0 NA During pregnancy Benign NA
Tsuda [24] 28 14 10 10 During pregnancy Benign +/+
Present case 33 7.6 16 2,157 After delivery Benign +/+
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